Guidelines of the French Society for Digestive Endoscopy (SFED): Management of patients on anticoagulants or antiplatelet agents before digestive endoscopy

Endoscopy

Volumn 38, Issue 6, 2006, Pages 632-638

  Napoléon, Bertrand ^a   Boneu, B ^b   Maillard, L ^c   Samama, C M ^d   Schved, J F ^b   Gay, G ^a   Ponchon, T ^a   Sautereau, D ^a   Canard, J M ^a  

^a Société Française d'Endoscopie Digestive SFED   (France)

^b Groupe d'Etude de l'Hémostase et de la Thrombose GEHT

^c Société Française de Cardiologie SFC

^d Société Française d'Anesthésie et de Réanimation SFAR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; DIPYRIDAMOLE; FLURBIPROFEN; FONDAPARINUX; HEPARIN; HEPARIN CALCIUM; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PROTHROMBIN COMPLEX; RAPAMYCIN; TICLOPIDINE; XIMELAGATRAN;

ANTICOAGULATION; ARTICLE; BLEEDING; CONSENSUS DEVELOPMENT; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFICACY; DRUG ELIMINATION; DRUG ELUTING STENT; DRUG HALF LIFE; DRUG INDICATION; DRUG REEXPOSURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FRANCE; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM;

ANTICOAGULANTS; ENDOSCOPY, DIGESTIVE SYSTEM; FRANCE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; PLATELET AGGREGATION INHIBITORS; SOCIETIES, MEDICAL;

EID: 33745529782     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925086     Document Type: Article

References (41)

1. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002; 55: 775-779
2. Miller AM, McGill D, Bassett ML. Anticoagulant therapy, antiplatelet agents and gastrointestinal endoscopy. J Gastroenterol Hepatol 1999; 14: 109-113
3. Hittelet A, Devière J. Management of anticoagulants before and after endoscopy. Can J Gastroenterol 2003; 17: 329-332
4. Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. J Clin Gastroenterol 1994; 19: 283-287
5. Bergman JJ, Rauws EA, Fockens P, vanBerkel AM, Bossuyt PM, Tijssen JG et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet 1997; 349: 1124-1129
6. O'Laughlin JC, Hoftiezer JW, Mahoney JP, Ivey KJ. Does aspirin prolong bleeding from gastric biopsies in man? Gastrointest Endosc 1981; 27: 1-5
7. Waye J. Colonoscopy. CA Cancer J Clin 1992; 42: 350-365
8. Remine SG, Hughes RW, Weiland LH. Endoscopic gastric polypectomy. May Clin Proc 1981; 56: 371-375
9. Ahmad NA, Kochman ML, Long WB, Furth EE, Ginsberg GG. Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002; 55: 390-396
10. Binmoeller KF, Boaventura S, Ramsperger K, Soehendra N. Endoscopic snare excision of benign adenomas of the papilla of Vater. Gastrointest Endosc 1993; 39: 127-131
11. Cotton PB, Lehman G, Vennes J, Geenen JE, Russel RC, Meyers WC et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-393
12. Mathus-Vliegen EM, Tytgat GN. Nd:YAG laser photocoagulation in colorectal adenoma. Evaluation of its safety, usefulness and efficacy. Gastroenterology 1986; 90: 1865-1873
13. Piai G, Cipolletta L, Claar M, Marone G, Bianco MA, Forte G et al. Prophylactic sclerotherapy of high rish esophageal varices: results of a multicentric prospective controlled trial. Hepatology 1988; 8: 1495-1507
14. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326: 1527-1532
15. Jensen DM. Endoscopic control of non variceal upper gastrointestinal hemorrhage. In: Yamada T, Alpers DH, Laine L, Owyang C, Powell DW (eds). Textbook of gastroenterology. Philadelphia: Lippincott Williams and Wilkins, 1999: 2857-2879
16. Napoléon B. Ponction sous éhoendoscopie: un geste utile ou dangereux? Gastroentérol Clin Biol 1999; 23: 459-462
17. Larson DE, Burton DD, Schroeder KW, DiMagno EP. Percutaneous endoscopic gastrostomy. Indications, success, complications, and mortality in 314 consecutive patients. Gastroenterology 1987; 93: 48-52
18. Neuhaus H, Hoffman W, Dittler HJ, Niedermeyer HP, Classen M. Implantation of self-expanding esophageal metal stents for palliation of malignant dysphagia. Endoscopy 1992; 24: 405-410
19. Faigel DO. Endoscopy for the diagnosis and management of esophageal cancer. ASGE Clinical Update 2000; 8: 1-4
20. Dumortier J, Napoléon B, Hedelius F, Pellissier PE, Leprince E, Pujol B et al. Unsedated transnasal EGD in daily practice: Results with 1100 consecutive patients. Gastrointest Endosc 2003; 57: 198-204
21. Patrono C, Coller B, Dalen JE, FitzGerald GA, Fuster V, Gent M et al. Platelet-active drugs: the relationships among dose, effectiveness, and optimal therapeutic range. Chest 2001; 119 (1 Suppl): 39S-63S
22. Samama CM, Djoudi R, Lecompte T, Nathan-Denizot N, Schved JF and the AFSSAPS expert group. Perioperative platelet transfusion: recommendations of the Agence frana̧ise de sécurité sanitaire des produits de santé (AFSSaPS) 2003. Can J Anesth 2005; 52: 30-37
23. Brochier ML for the Flurbiprofen French Trial. Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. Eur Heart J 1993; 14: 951-957
24. Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDs. Gastrointest Endosc 1994; 40: 458-462
25. Hui AJ, Wong RMY, Ching JYL, Hung LCT, Chung SCS, Sung JJY. Risk of colonoscopy polypectomy bleeding with anticoagulants and anti-platelet agents: analysis of 1657 cases. Gastrointest Endosc 2004; 59: 44-48
26. Yousfi M, Gostout CJ, Baron TH, Hernandez JL, Keate R, Fleischer DE, Sorbi D. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004; 99: 1785-1789
27. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ et al. Complications of endoscopic biliary sphincterotomy. N Eng J Med 1996; 335: 909-918
28. Rogers JE, Fleming BG, Macintosh KC, Johnston B, Morgan-Hughes JO. Effect of timing of ketorolac administration on patient-controlled opiod use. Br J Anaesth 1995; 75: 15-18
29. Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, Feldman H et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. Jama 1996; 275: 376-382
30. Ferraris VA, Swanson E. Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. Surg Gynecol Obstet 1983; 156: 439-442
31. CAPRIE Steering Committee. A randomised, blinded trial of clopridrogel versus aspirin in patients at risk of ischemic events. Lancet 1996; 348: 1329-1339
32. Conférence d'experts: Société Française d'Anesthésie et de Réanimation, Groupe d'étude sur l'hémostase et la thrombose de la société franŗaise d'hématologie. Agents antiplaquettaires et période périopératoire. Paris: Elsevier, 2002: 7-139
33. Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288-1294
34. Boneu B, Schved JF, Lecompte T, Alessi MC et le groupe d'études sur I'hémostase et la thrombose. Utilisation des traitements antithrombotiques en pratique médicale courante. STV numéro spécial 2000; 12: 2-55
35. Orford JL, Lennon R, Melby S, Fasseas P, Bell MR, Rihal CS et al. Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. J Am Coll Cardiol 2002; 40: 1567-1572
36. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665-1671
37. Recommandations de la Société Française de Cardiologie concernant les indications et la surveillance des traitements par anticoagulants oraux. AMC 1997; 9: 1289-1305
38. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C et al. CREDO investigators. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama. 2003; 289: 987
39. Waksman R, Ajani AE, White RL, Pinnow E, Dieble R, Bui AB et al. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS). Circulation 2001; 103: 2332-2335
40. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al RAVEL Study Group. Randomized study with the Sirolimus-Coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780
41. Stein PD, Alpert JS, Bussey HI, Dalen JE, Turpie AG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 2001; 119 (1 Suppl): 220S-227S